Market revenue in 2023 | USD 1,128.8 million |
Market revenue in 2030 | USD 2,481.0 million |
Growth rate | 11.9% (CAGR from 2023 to 2030) |
Largest segment | Disposable equipment |
Fastest growing segment | Disposable Equipment |
Historical data covered | 2018 - 2022 |
Base year for estimation | 2023 |
Forecast period covered | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | Disposable Equipment, Capital Equipment, Reusable Equipment |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Stryker Corp, Abbott Laboratories, Smith & Nephew PLC, Johnson & Johnson, AngioDynamics Inc |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to radiofrequency ablation devices market will help companies and investors design strategic landscapes.
Disposable equipment was the largest segment with a revenue share of 42.79% in 2023. Horizon Databook has segmented the Europe radiofrequency ablation devices market based on disposable equipment, capital equipment, reusable equipment covering the revenue growth of each sub-segment from 2018 to 2030.
The radiofrequency ablation devices market in Europe is likely to grow at a CAGR of 11.6% during the forecast period. The growth of this market can be attributed to the launch of advanced devices, rising geriatric population, increasing prevalence of cardiac diseases & cancer, and rising adoption of minimally invasive procedures.
This system is used in the treatment of ventricular tachycardias. In Europe, Cardiovascular Diseases (CVDs) remain the main cause of death in most of the countries. In 2012, these diseases costed about USD 232 billion to the European economy.
The overall cost incurred due to CVDs in the European Union, about 54% can be attributed to healthcare, 24% to productivity loss, and 22% to the carelessness of people suffering from CVDs. In addition, in 2012, RFAAcademia launched an initiative to boost awareness among Europeans.
Horizon Databook provides a detailed overview of continent-level data and insights on the Europe radiofrequency ablation devices market , including forecasts for subscribers. This continent databook contains high-level insights into Europe radiofrequency ablation devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account